Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels.

scientific article published on 25 February 2014

Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/LT.23831
P698PubMed publication ID24477986

P50authorBong-Soo ChaQ61196432
Myoung Soo KimQ84974983
Yongin ChoQ85778587
Eun Seok KangQ59703034
P2093author name stringDong Jin Joo
Min Jung Lee
Chang Hee Jung
Joong-Yeol Park
Eun Yeong Choe
P2860cites workStatins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsQ29622947
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up studyQ33937741
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysisQ34027392
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trialQ34293369
Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesityQ34426367
Effects of statins on energy and fatigue with exertion: results from a randomized controlled trialQ34847163
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubesQ35855311
Transplanted liver: consequences of denervation for liver functionsQ35894480
Mitochondrial dysfunction in white adipose tissueQ36198938
Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up.Q36696738
New onset diabetes mellitus after solid organ transplantationQ36993705
Mitochondrial dysfunction in pancreatic beta-cells in Type 2 diabetesQ37209210
Management of cardiovascular risk: the importance of meeting lipid targetsQ38018650
New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantationQ38043070
Do statins cause diabetes?Q38086101
Adult-to-adult living donor liver transplantation at the Asan Medical Center, Korea.Q38521548
Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cellsQ39965445
Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factorsQ42209549
Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing databaseQ42656443
The effect of insulin-dependent diabetes mellitus on outcome of liver transplantationQ42686323
Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea.Q43278824
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortalityQ43752482
Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipientsQ44051171
Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantationQ44195066
New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.Q44789148
Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.Q45962265
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantationQ46480478
Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantationQ46580991
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimusQ46645985
New-onset diabetes after liver transplantationQ46719525
Weight change and obesity after liver transplantation: incidence and risk factorsQ47286068
Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.Q51466759
Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients.Q51476761
Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.Q51482450
A Polymorphism in the Zinc Transporter Gene SLC30A8 Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft RecipientsQ57500079
P433issue5
P921main subjectstatin therapyQ62562875
P304page(s)557-563
P577publication date2014-02-25
P1433published inLiver TransplantationQ15730498
P1476titleStatin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels
P478volume20

Reverse relations

cites work (P2860)
Q90601583Incidence of Recurrent NASH-Related Allograft Cirrhosis
Q38543105Non-alcoholic fatty liver disease following liver transplantation: a clinical review.
Q39004220Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation
Q53755580Pharmacometabolomic signature links simvastatin therapy and insulin resistance.
Q50145783Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment
Q36541052Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Q37205087Prevalence, predictive factors, and survival outcome of new-onset diabetes after liver transplantation: A population-based cohort study.
Q61799108Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Q52607836Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis.

Search more.